Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Vera Therapeutics, Inc.

Vera Therapeutics, Inc. (VERA) Stock Overview

Explore Vera Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

VERA●NASDAQ
HealthcareBiotechnology
$33.05
$1.00(2.94%)
U.S. Market is Open · 10:26

Vera Therapeutics, Inc. (VERA)

Meyka AI Score

Z

Key Financials

Market Cap2.4B
P/E Ratio-5.79
EPS (TTM)$-5.86
ROE-0.84%
Fundamental Analysis

AI Price Forecasts

1 Month$41.16
3 Months$61.80
1 Year Target$45.26

VERA Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Vera Therapeutics, Inc. (NASDAQ: VERA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Vera Therapeutics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of VERA on the NASDAQ shows an RSI of 47.93, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $45.26 for the NASDAQ listing.

Key metrics behind Vera Therapeutics, Inc.'s NASDAQ-traded stock include a P/E ratio of -5.79 and a market capitalization of 2.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of VERA on the NASDAQ.

Price Performance (NASDAQ: VERA)

1-Day Change
-1.12%
5-Day Change
0.54%
1-Month Change
6.45%
3-Month Change
-1.66%
6-Month Change
-15.74%
Year-to-Date (YTD) Change
-33.51%
1-Year Change
38.90%
3-Year Change
97.02%
5-Year Change
10.03%
All-Time (Max) Change
192.78%

Contact Information

https://veratx.com
650 770 0077
2000 Sierra Point Parkway, Brisbane, CA, 94005

Company Facts

3,610 Employees
IPO DateMay 14, 2021
CountryUS
Actively Trading

Frequently Asked Questions